National Comprehensive Cancer Network



About NCCN

Breast Cancer Panel - Disclosures as of 5/24/2013

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Benjamin O. Anderson, MD

General Electric;
sanofi-aventis U.S.

None

None

None

5/28/2012

Harold J. Burstein, MD, PhD

None

None

None

None

5/23/2013

Amy Cyr, MD

None

None

None

None

5/22/2013

Stephen B. Edge, MD

None

None

None

None

6/5/2012

William B. Farrar, MD

None

None

None

None

6/18/2012

Andres Forero, MD

Abbott Laboratories;
Biogen Idec;
Celgene Corporation;
Daiichi- Sankyo Co.;
Eisai Inc.;
Eli Lilly and Company;
Genentech, Inc.;
BioCryst;
Immunomedics;
Seattle Genetics

None

None

None

5/5/2012

Lauren Gallagher, RPh, PhD

None

None

None

None

6/5/2012

Sharon Hermes Giordano, MD, MPH

None

None

None

None

5/1/2012

Lori J. Goldstein, MD

Novartis Pharmaceuticals Corporation;
Dompe

Celgene Corporation;
Eisai Inc.;
Genomic Health, Inc.

None

Genentech, Inc.;
Novartis Pharmaceuticals Corporation

7/13/2012

William J. Gradishar, MD

None

Bayer HealthCare;
Eisai Inc.;
Genentech, Inc.;
Genomic Health, Inc.;
Myriad Genetic Laboratories, Inc.;
Onyx Pharmaceuticals, Inc.

None

None

1/21/2013

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

Daniel F. Hayes, MD

Novartis Pharmaceuticals Corporation;
Janssen R&D, LLC;
Pfizer Inc.;
Veridex, LLC

None

None

None

6/6/2012

Clifford A. Hudis, MD

None

None

None

None

8/9/2012

Steven Jay Isakoff, MD, PhD

Abbott Laboratories

Myriad Genetic Laboratories, Inc.

None

None

3/7/2013

Rashmi Kumar, PhD

None

None

None

None

2/15/2012

Britt-Marie E. Ljung, MD

National Cancer Institute

None

None

None

1/31/2013

P. Kelly Marcom, MD

Genentech, Inc.;
Novartis Pharmaceuticals Corporation;
DoD/CDMRP

Genentech, Inc.

None

None

6/20/2011

Ingrid A. Mayer, MD

None

None

None

None

10/1/2012

Joan S. McClure, MS

None

None

None

None

7/23/2012

Beryl McCormick, MD

None

None

None

None

6/15/2012

Mark Pegram, MD

        

Pending

Lori J. Pierce, MD

None

Genomic Health, Inc.

UpToDate

None

6/11/2012

Elizabeth C. Reed, MD

Novartis Pharmaceuticals Corporation

UnitedHealthcare

None

None

5/8/2012

Lee S. Schwartzberg, MD, FACP

Bristol-Myers Squibb Company;
Eisai Inc.

Amgen Inc.;
Eisai Inc.;
Genentech, Inc.;
GlaxoSmithKline

None

None

6/6/2012

Dorothy Shead, MS

None

None

None

None

8/3/2012

Mary Lou Smith, JD, MBA

Genentech, Inc.

AstraZeneca Pharmaceuticals LP

None

Gateway for Cancer Research Foundation;
National Accreditation Program for Breast Centers

2/1/2013

Hatem Soliman, MD

Agendia BV

Agendia BV;
Celgene Corporation;
NanoString;
Veridex, LLC

None

None

12/5/2012

George Somlo, MD

AstraZeneca Pharmaceuticals LP;
Celgene Corporation;
Genentech, Inc.;
National Cancer Institute;
Veridex, LLC

Celgene Corporation;
Genentech, Inc.;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
Abraxane;
Roche Laboratories, Inc.

None

None

8/16/2012

Richard L. Theriault, DO, MBA

None

None

None

None

1/30/2013

John H. Ward, MD

None

None

None

None

1/17/2013

Antonio C. Wolff, MD

Bristol-Myers Squibb Company;
Genentech, Inc.

None

None

None

6/9/2012

Richard Zellars, MD

None

None

None

None

9/6/2012

 

About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved